Geri

Yatırım Faaliyetlerinden Gelen Nakit'in Neumora Therapeutics, Inc.

Yıllık veri
2022
2023
2024
TTM
‪‪−210,00 M‬‬
‪‪−140,00 M‬‬
‪‪−70,00 M‬‬
‪0,00‬
‪‪70,00 M‬‬
Dönem
Değer
Değişim
Değişim %
TTM
‪‪−70,56 M‬‬
‪0,00‬
‪0,00‬%
2024
‪‪−70,56 M‬‬
‪‪−134,94 M‬‬
‪−209,58‬%
2023
‪‪64,39 M‬‬
+‪‪232,40 M‬‬
2022
‪‪−168,01 M‬‬
‪‪−167,20 M‬‬
‪‪−20,46 K‬‬%
3 ay veri
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−160,00 M‬‬
‪‪−80,00 M‬‬
‪0,00‬
‪‪80,00 M‬‬
‪‪160,00 M‬‬
Dönem
Değer
Değişim
Değişim %
Q4 '24
‪‪−98,80 M‬‬
‪‪−255,79 M‬‬
‪−162,93‬%
Q3 '24
‪‪156,99 M‬‬
+‪‪135,73 M‬‬
+‪638,59‬%
Q2 '24
‪‪21,25 M‬‬
+‪‪171,26 M‬‬
Q1 '24
‪‪−150,00 M‬‬
‪‪−163,68 M‬‬
‪‪−1,20 K‬‬%
Q4 '23
‪‪13,68 M‬‬
‪‪−10,14 M‬‬
‪−42,57‬%
Q3 '23
‪‪23,82 M‬‬
‪‪−263,00 K‬‬
‪−1,09‬%
Q2 '23
‪‪24,08 M‬‬
+‪‪21,26 M‬‬
+‪754,74‬%
Q1 '23
‪‪2,82 M‬‬
+‪‪10,85 M‬‬
Q4 '22
Q3 '22
Q2 '22
Q1 '22